PharmaCyte Biotech, Inc. Annual Nonoperating Income (Expense) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
PharmaCyte Biotech, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2011 to 2023.
  • PharmaCyte Biotech, Inc. Nonoperating Income (Expense) for the quarter ending July 31, 2024 was $24.7M.
  • PharmaCyte Biotech, Inc. Nonoperating Income (Expense) for the twelve months ending July 31, 2024 was $34.7M, a 3768% increase year-over-year.
  • PharmaCyte Biotech, Inc. annual Nonoperating Income (Expense) for 2023 was $8.85M, a 314% increase from 2022.
  • PharmaCyte Biotech, Inc. annual Nonoperating Income (Expense) for 2022 was $2.14M, a 1300% increase from 2021.
  • PharmaCyte Biotech, Inc. annual Nonoperating Income (Expense) for 2021 was $153K, a 113% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $8.85M +$6.71M +314% May 1, 2023 Apr 30, 2024 10-K 2024-08-13
2022 $2.14M +$1.99M +1300% May 1, 2022 Apr 30, 2023 10-K 2024-08-13
2021 $153K +$81.1K +113% May 1, 2021 Apr 30, 2022 10-K 2023-07-31
2020 $71.7K May 1, 2020 Apr 30, 2021 10-K 2022-07-28
2012 $86.3K +$36.4K +73% May 1, 2012 Apr 30, 2013 10-K 2013-07-29
2011 $49.9K May 1, 2011 Apr 30, 2012 10-K 2013-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.